We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+6.77%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$31.8B
AUM Growth
+$4.92B
Cap. Flow
+$3.43B
Cap. Flow %
10.78%
Top 10 Hldgs %
25.98%
Holding
2,274
New
181
Increased
1,795
Reduced
280
Closed
17

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$289M
2
AAPL icon
Apple
AAPL
+$260M
3
MSFT icon
Microsoft
MSFT
+$231M
4
IBM icon
IBM
IBM
+$124M
5
TSLA icon
Tesla
TSLA
+$123M

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$118M
2
CARR icon
Carrier Global
CARR
+$113M
3
OTIS icon
Otis Worldwide
OTIS
+$105M
4
ALB icon
Albemarle
ALB
+$65.6M
5
XOM icon
ExxonMobil
XOM
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 25.63%
2 Consumer Discretionary 15.64%
3 Communication Services 10.33%
4 Financials 9.6%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STR
2226
DELISTED
Sitio Royalties
STR
$46K ﹤0.01%
+2,551
New +$40.5K
TLPH icon
2227
Talphera
TLPH
$67M
$46K ﹤0.01%
1,341
+454
+51% +$18K
FRBK
2228
DELISTED
Republic First Bancorp Inc
FRBK
$46K ﹤0.01%
12,146
+2,078
+21% +$7.12K
ALSK
2229
DELISTED
Alaska Communications Systems
ALSK
$46K ﹤0.01%
14,003
+2,508
+22% +$8.22K
MBIO icon
2230
Mustang Bio
MBIO
$4.94M
$45K ﹤0.01%
18
+3
+20% +$8.92K
MLSS icon
2231
Milestone Scientific
MLSS
$37.6M
$44K ﹤0.01%
12,297
+2,105
+21% +$7.21K
CKPT
2232
DELISTED
Checkpoint Therapeutics
CKPT
$43K ﹤0.01%
1,383
+239
+21% +$8.01K
DHX icon
2233
DHI Group
DHX
$175M
$43K ﹤0.01%
12,824
+2,191
+21% +$6.24K
CASI
2234
DELISTED
CASI Pharmaceuticals
CASI
$42K ﹤0.01%
1,767
+302
+21% +$8.48K
ENZ
2235
DELISTED
Enzo Biochem, Inc.
ENZ
$41K ﹤0.01%
+11,869
New +$36.9K
CRBP icon
2236
Corbus Pharmaceuticals
CRBP
$165M
$40K ﹤0.01%
684
+117
+21% +$7.69K
PXLW icon
2237
Pixelworks
PXLW
$35.6M
$40K ﹤0.01%
+1,015
New +$42.3K
ABUS icon
2238
Arbutus Biopharma
ABUS
$871M
$39K ﹤0.01%
11,750
-1,354
-10% -$5.22K
RVLP
2239
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$39K ﹤0.01%
12,053
-421
-3% -$1.73K
MBII
2240
DELISTED
Marrone Bio Innovations, Inc.
MBII
$39K ﹤0.01%
18,530
+3,166
+21% +$6.58K
SNCR
2241
DELISTED
Synchronoss Technologies
SNCR
$38K ﹤0.01%
+1,172
New +$48.4K
AGRX
2242
DELISTED
Agile Therapeutics
AGRX
$38K ﹤0.01%
9
+1
+13% +$5.41K
PVLA
2243
Palvella Therapeutics
PVLA
$1.78B
$36K ﹤0.01%
177
+30
+20% +$6.56K
OSG
2244
DELISTED
Overseas Shipholding Group Inc.
OSG
$36K ﹤0.01%
17,640
+3,011
+21% +$6.64K
EVFM
2245
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$36K ﹤0.01%
1,366
+233
+21% +$10.6K
AVTX icon
2246
Avalo Therapeutics
AVTX
$957M
$35K ﹤0.01%
+4
New +$37.8K
XCUR icon
2247
Exicure
XCUR
$12M
$35K ﹤0.01%
106
+18
+20% +$6.2K
SREV
2248
DELISTED
ServiceSource International, Inc.
SREV
$35K ﹤0.01%
23,573
+4,028
+21% +$6.65K
SB icon
2249
Safe Bulkers
SB
$729M
$34K ﹤0.01%
13,866
+2,369
+21% +$5.58K
TYME
2250
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$33K ﹤0.01%
18,562
+3,175
+21% +$6.59K

Similar funds

ProShare Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, ProShare Advisors held 2,274 positions worth $31.8B, up 18% from $26.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

ProShare Advisors deployed $3.43B of net new capital in Q1 2021, opening 181 new positions and adding to 1,795 existing holdings. Its largest new stake was SelectQuote: 34,916 shares worth $1.03M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was RTX Corp, an estimated $118M trimmed.

  • ProShare Advisors's largest Q1 2021 buy was SelectQuote: 34,916 shares worth $1.03M.
  • ProShare Advisors added most to Amazon in Q1 2021, an estimated $289M increase.
  • ProShare Advisors's biggest Q1 2021 reduction was RTX Corp, cutting an estimated $118M.
  • ProShare Advisors fully exited Eaton Vance Corp. in Q1 2021, selling an estimated $18M.
  • ProShare Advisors's ten largest holdings make up 26% of its $31.8B portfolio in Q1 2021.
  • ProShare Advisors opened 181 new positions and closed 17 in Q1 2021.
  • ProShare Advisors's portfolio value rose 18% quarter-over-quarter to $31.8B.

Based on ProShare Advisors's 13F filing for Q1 2021, filed 14 May 2021.